相关实验视频
Updated: Jan 20, 2026
01:26
Angina IV: Management
Published on: June 19, 2025
241
血管缩性心血管炎的突然死亡无法通过医疗管理
1Department of Cardiology, Hull University Teaching Hospitals NHS Trust, Hull, GBR.
Cureus
|January 19, 2026
概括
这项案例研究突出了一个罕见的,严重的血管性心痛 (VSA) 病例不耐治疗,导致致命的心室动. 早期识别和优化血管扩展剂治疗对于管理VSA和预防心脏突然死亡至关重要.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床病例报告 临床病例报告
背景情况:
- 血管性心痛 (VSA) 涉及暂时的冠状动脉,导致心肌缺血.
- 虽然常常对血管扩张剂有反应,但一些VSA病例在医学上变得不耐药,导致严重的并发症.
- 与暂时的ST段升高相关的经常性昏迷和胸痛可能表明VSA.
研究的目的:
- 报告一个独特的医疗不耐药的血管性心痛病例.
- 为了说明管理严重的VSA所面临的挑战.
- 为了强调耐火性VSA中突然心脏死亡的风险.
主要方法:
- 一个50多岁的男性患者的病例报告,胸部反复疼痛和昏迷.
- 诊断工作包括冠状动脉血管学和心脏MRI.
- 连续遥测监测和植入式循环记录器用于节律监测.
主要成果:
- 患者出现了反复复发的血管发作,尽管增加了包括通道阻塞剂和酸盐在内的医疗治疗.
- 冠状动脉扫描和心脏MRI显示冠状动脉解剖是正常的,没有结构性心脏病.
- 该患者因心室动而经历了医院外心脏骤停,导致死亡.
结论:
- 血管紧张性心痛可以呈现为一种严重的,耐火性疾病.
- 优化血管扩张器治疗和勤奋的节律监测在VSA管理中至关重要.
- 尽管经过最佳管理,但耐火性VSA具有致命心律失常和突然心脏死亡的显著风险.
相关概念视频
Angina IV: Management
241
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
241
Angina V: Nursing Management
300
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
300
Heart Failure V: Medical Management
224
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
224
Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
Myocarditis III: Medical Management
179
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
179
Pericarditis III: Medical Management
317
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
317